SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?


To: Arthur Radley who wrote (10221)9/29/2009 6:14:30 PM
From: Qualified Opinion  Respond to of 10345
 
New Issue-Elan sells $625 mln in 7-yr senior notes
Tue Sep 29, 2009 5:47pm EDT

Sept 29 (Reuters) - Elan Finance Plc and Elan Finance
Corp, units of Elan Corporation Plc (ELN.N), on Tuesday sold
$625 million of senior notes in the 144a private placement
market, said market sources. The size of the deal was increased from an originally
planned $600 million. Morgan Stanley and Citigroup were the joint bookrunning
managers for the sale.
BORROWER: ELAN FINANCE PLC ELAN FINANCE CORP
AMT $625 MLN COUPON 8.750 PCT MATURITY 10/15/2016
TYPE SNR NOTES ISS PRICE 98.710 FIRST PAY 4/15/2010
MOODY'S B2 YIELD 9.0 PCT SETTLEMENT 10/2/2009
S&P SINGLE-B SPREAD 606 BPS PAY FREQ SEMI-ANNUAL
FITCH N/A MORE THAN TREAS NON-CALLABLE 3 YEARS*
*MAKE-WHOLE CALL 50 BPS.